Increased transvascular lipoprotein transport in diabetes: Association with albuminuria and systolic hypertension

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 8, 2005, Pages 4441-4445

  Jensen, Jan Skov ^a,c,d   Feldt Rasmussen, Bo ^a   Borch Johnsen, Knut ^b   Jensen, Kurt Svarre ^a   Nordestgaard, Børge Grønne ^c,d  

^a Rigshospitalet   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES CONTROL; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN GLYCOSYLATION; PROTEIN TRANSPORT; PROTEINURIA; RANDOMIZATION; SAMPLE SIZE; SYSTOLIC HYPERTENSION;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; ARTERIOSCLEROSIS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PARTICLE SIZE; RECEPTORS, LDL; RISK FACTORS;

EID: 23844479558     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-2420     Document Type: Article

References (39)

1. Schnohr P, Jensen JS, Scharling H, Nordestgaard BG 2002 Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12,000 men and women. Eur Heart J 223:620-626
2. Borch-Johnsen K, Kreiner S 1987 Proteinuria - value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 294:1651-1654
3. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T 1987 Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30:144-148
4. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH 1995 Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 44:1303-1309
5. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH 1996 Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. Br Med J 313:779-784
6. Jensen T, Borch-Johnsen K, Deckert T 1987 Changes in blood pressure and renal function in patients with type 1 (insulin-dependent) diabetes mellitus prior to clinical diabetic nephropathy. Diabetes Res 4:159-162
7. Feldt-Rasmussen B 1986 Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 29:282-286
8. Nørgaard K, Jensen T, Feldt-Rasmussen B 1993 Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:57-61
9. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A 1989 Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219-226
10. Nordestgaard BG, Nielsen LB 1994 Atherosclerosis and arterial influx of lipoproteins. Curr Opin Lipidol 5:252-257
11. Nordestgaard BG 1996 The vascular endothelial barrier - Selective retention of lipoproteins. Curr Opin Lipidol 7:269-273
12. Kornerup K, Nordestgaard BG, Feldt-Rasmussen B, Borch-Johnsen K, Jensen KS, Jensen JS 2002 Transvascular low density lipoprotein transport in patients with diabetes mellitus (type 2). A noninvasive in vivo isotope technique. Arterioscler Thromb Vasc Biol 22:1168-1174
13. Kornerup K, Nordestgaard BG, Feldt-Rasmussen B, Borch-Johnsen K, Jensen KS, Jensen JS 2003 Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis. Atherosclerosis 70:163-168
14. Mogensen CE; Keane WF, Bennett PH, Jerums G, Parving H-H, Passa P, Steffes MW, Striker GE, Viberti GC 1995 Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080-1084
15. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M 2001 The Copenhagen City Heart Study. Østerbroundersøgelsen. Tables with data from the third examination 1991-1994. Eur Heart J 3(Suppl H):1-83
16. Nordestgaard BG, Zilversmit DB 1989 Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits. Arteriosclerosis 9:176-183
17. Sasaki J, Cottam GL 1982 Glycosylation of LDL decreases its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo. Biochim Biophys Acta 713:199-207
18. Lyons TJ 1992 Lipoprotein glycation and its metabolic consequences. Diabetes 41(Suppl 2):67-73
19. Bilheimer DW, Grundy SM, Brown MS, Goldstein JL 1983 Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci USA 80:4124-4128
20. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Ellam R, Steinberg D 1982 Nonenzymatic glucosylation of low-density lipoprotein alters its biological activity. Diabetes 31:283-291
21. Matthews CME 1957 The theory of tracer experiments with 131-I-labeled plasma proteins. Phys Med Biol 2:36-53
22. Barrett PHR, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster DM 1998 SAAM II: simulation, analysis, and modeling software for tracer and pharmacokinetic studies. Metabolism 47:484-492
23. Feldt-Rasmussen B, Deckert M, Dinesen B 1985 Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45:539-544
24. Krauss RM, Burke DJ 1982 Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104
25. Gall M-A, Rossing P, Skøtt P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P, Beck-Nielsen H, Parving H-H 1991 Prevalence of micro-and macroalbumnuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:655-661
26. Lin SJ, Jan KM, Weinbaum S, Chien S 1989 Transendothelial transport of low density lipoprotein in association with cell mitosis in rat aorta. Arteriosclerosis 9:230-236
27. Lin SJ, Jan KM, Chien S 1990 Role of dying endothelial cells in transendothelial macromolecular transport. Arteriosclerosis 10:703-709
28. Lin SJ, Hong CY, Chang MS, Chiang BN, Chien S 1993 Increased aortic endothelial death and enhanced transendothelial macromolecular transport in streptozotocin-diabetic rats. Diabetologia 36:926-930
29. Nestler JE, Barlascini CO, Tetrault GA, Fratkin GA, Clore JN, Blackward WG 1990 Increased transcapillary escape rate of albumin in nondiabetic men in response to hyperinsulinemia. Diabetes 39:1212-1217
30. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron A 1996 Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest 97:2601-2610
31. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, Matthaei S, Rett K, Haring HU 2000 Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101:1780-1784
32. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D 1994 Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14:1521-1528
33. Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, Hori O, Stern D, Schmidt AM 1996 Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 97:238-243
34. Schmidt AM, Yan SD, Wautier JL, Stern D 1999 Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84:489-497
35. Bonnardel-Phu E, Wautier JL, Schmidt AM, Avila C, Vicaut E 1999 Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 48:2052-2058
36. Litwak KN, Cefalu WT, Wagner JD 1998 Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys. Metabolism 47:947-954
37. Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE 2002 Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 25:2328-2334
38. Stender S, Hjelms E 1987 In vivo transfer of cholesterol from plasma into human aortic tissue. Scand J Clin Lab Invest Suppl 186:21-29
39. Stender S, Zilversmith DB 1981 Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. Molecular size as a determinant of plasma lipoprotein influx. Arteriosclerosis 1:38-49